I understand what you are saying ds but the only thing i have seen cause a major movement in share price in a long while based purely on PYC science, not actual deals or potential milestones was the news on the MYC developments. That was deflated by the fact we didnt have commercial access. Following this they hinted that they had a candidate of their own to replace omomyc which could be as effective if not better. After they first mentioned OMOMYC it did not take long to progress to the cell penetration tumor results. The fact that they have not followed this with an update this far down the track smacks at best of same old "but wait theres more " BS and there is no alternative, or at worst a completely manufactured and arranged pump and dump to clear the decks for the brokers and next CR.
Of course there could still be a halt any moment and an update- that's what is so frustrating. I guess it is still not the normal 15 months yet that they wait to announce something that has not worked out. 30/03/15 was the announcement on Cancer success with omomyc so only 5 months. Surely its just a case of repeating same trials with the PYC owned alternative?? I would have thought they know by now though.
PYC Price at posting:
1.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)